Fox Chase Cancer Center Rated Best in Philadelphia for Surgical Outcomes
New Consumer Reports study looks at mortality rates and length of hospital stays at 2,463 hospitals nationwide
PHILADELPHIA, PA (August 6, 2013)—A new Consumer Reports study that examines the mortality rates and length of hospital stays for different types of elective surgeries rated Fox Chase Cancer Center as having the best surgical outcomes of any hospital in the city of Philadelphia. The study looked at patients from 2,463 hospitals nationwide, including 32 hospitals in the Philadelphia area.
“This is terrific and welcome news, and an emphatic validation of our longstanding commitment to patient safety and dedication to achieving the best outcomes for our patients who entrust us with their cancer care,” says Richard I. Fisher, MD, President and CEO of Fox Chase Cancer Center and Senior Associate Dean at Temple University School of Medicine.
To conduct the study, Consumer Reports worked with a health care consulting firm with expertise in analyzing billing claims and clinical records data and in helping hospitals use that information to improve patient safety. The study looked at Medicare claims data from 2009 through 2011 for patients undergoing 27 categories of common scheduled surgeries, which was used to calculate an overall rating for each hospital.
For a full description of the methodology, go to www.ConsumerReports.org/hospitalratings.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.